Metabiota

Metabiota

Metabiota was founded by Nathan Wolfe, a virologist known for early work on pandemic origins — including studies of monkeypox and simian viruses in Cameroon (per PLoS One, 2013). The firm operates from San Francisco, New Haven, and London, but its founding year and current ownership structure are not publicly disclosed. The firm develops AI models for infectious disease risk — covering viruses, bacteria, and parasites across humans, animals, and vectors. It focuses on biosurveillance analytics, climate-disease modeling, and outbreak forecasting. Metabiota publishes research on pathogens such as Ebola, monkeypox, and hepatitis C, often in collaboration with the US Department of Defense and global health agencies (per PLoS Neglected Tropical Diseases, 2011; Emerging Infectious Diseases, 2011). Its geographic focus includes Central Africa, Southeast Asia, and South Asia. Metabiota's team size and deployment capital are not publicly reported. The firm maintains an active research publication record with dozens of peer-reviewed papers from 2008–2013 on topics from HIV to hantavirus. No recent operational event — such as a funding round, contract win, or leadership change — is publicly available from the last 24 months. Metabiota's structural differentiator is its foundational role in the pandemic-prep tech vertical: it originated as a research spinout blending field epidemiology with data science, a model distinct from typical biotech or analytics firms. Its governance and any connection to a family office or endowment remain undisclosed.